Fundraising FoxKSP, Inc.
Venture capitalKawasaki · Seed–Growth · 1 people tracked
Also known as 株式会社ケイエスピー
Find your way into KSP, Inc.
Sign up to find every way you can get introduced to KSP, Inc.
- Your email: who you already know at KSP, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the KSP, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
KSP supports the commercialization of technology-driven ventures and researchers under a mission of developing Japan's brainpower resources. It operates three science parks in Kawasaki offering rental offices/labs and incubation services, and it forms and manages the 'KSP Investment Fund' targeting high-tech startups in early to middle stages with growth potential. Founded in 1997 as Japan's first incubation-type venture capital, it has taken 21 companies public. KSP also runs deep-tech acceleration programs, a business innovation school, business matching, and focused support for regenerative/cell medicine, providing hands-on mentoring to commercialize university and corporate technologies.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 5 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×2Digital Health ×1Longevity ×1
HQs:Japan×2
Investments · 5 tracked
founders shown can be your intro pathMegakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications.
BiotechHealthtechLongevityMedical DevicesKyoto, JP
Co-investorsMiyako CapitalDBJ CapitalJapan Asia InvestmentMitsubishi UFJ CapitalMizuho CapitalNissay Capital+1 more
J-Pharma is a drug development company focused on SLC transporter-targeted therapies, with its lead LAT1 inhibitor nanvuranlat (JPH203) in a global Phase 3 trial for biliary tract cancer and other candidates addressing cancer, autoimmune, and rare diseases.
BiotechDigital HealthHealthtechMedical DevicesTokyo, JP
𠮷武 益広(代表取締役社長 (Representative Director & President))藤本 裕(取締役CFO)山本 寛(取締役CBO)
Co-investorsF-Prime CapitalNewton BiocapitalOita Venture CapitalOSAKA University Venture CapitalSeibu Shinkin CapitalUntroD Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
アップコン株式会社株式会社インテリジェントセンサーテクノロジー株式会社ミンカブ・ジ・インフォノイド
Frequently asked questions
- How many investments has KSP, Inc. made?
- KSP, Inc. has 5 tracked investments.
- What stage does KSP, Inc. invest at?
- KSP, Inc. invests at the Seed, Series A, Series B, Growth stages.
- What sectors does KSP, Inc. focus on?
- KSP, Inc. focuses on Biotech, Data & Infrastructure, Deep Tech, Enterprise Software, Hardware, Medical Devices, SaaS, Sector Agnostic, Semiconductors.
- Where is KSP, Inc. located?
- KSP, Inc. is headquartered in Kawasaki, JP.
- Who does KSP, Inc. co-invest with?
- KSP, Inc. most often shares deals with F-Prime Capital, Mobile Internet Capital, Inc., Oita Venture Capital, among 8 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
SIB is a Dresden-based investment company providing equity/participation capital (Beteiligungskapital) to companies for growth, acquisitions, succession, equity increases, new ventures and restarts. It is a subsidiary of Ostsächsische Sparkasse Dresden.